CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


NO intervention planned due to the observational study design - only a diagnostic testingWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug2981 recombinant human interferon Alpha-1b Wiki 1.00
drug3030 thymosin alpha 1 Wiki 1.00

Correlated MeSH Terms (2)


Name (Synonyms) Correlation
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Slovenian National COVID-19 Prevalence Study

The investigators are conducting a national COVID-19 prevalence survey on a sample of 3,000 inhabitants that were randomly selected from the Slovenian population. The sample is representative in age, gender, and geographical distribution. The main objective is to assess how many people in Slovenia have COVID-19 in April/May 2020 and how many were infected with SARS-CoV-2 previously. The investigators are using a direct detection of SARS-CoV-2 RNA in nasopharyngeal samples with validated two-target PCR-based commercial assay. For a serological response to the etiological agent, IgG and IgA anti-SARS-CoV-2 antibodies are measured in plasma samples using a validated commercial assay.

NCT04376996 COVID-19 SARS-CoV-2 Diagnostic Test: NO intervention planned due to the observational study design - only a diagnostic testing

Primary Outcomes

Description: Prevalence of SARS-CoV-2 RNA in nasopharyngeal samples

Measure: Prevalence of SARS-CoV-2 RNA in nasopharyngeal samples

Time: April to May 2020

Description: Prevalence of anti-SARS-CoV-2 antibodies in blood samples

Measure: Prevalence of anti-SARS-CoV-2 antibodies in blood samples

Time: April to November 2020


No related HPO nodes (Using clinical trials)